VILLA GUARDIA (COMO), Italy--(BUSINESS WIRE)--Feb. 2, 2006--Gentium S.p.A. (AMEX:GNT) (the “Company”) today reported that on February 7, 2006, Guenther Eisser, Chief of Biology Research for Gentium, will present a poster entitled, “Defibrotide, an endothelium stabilizing drug, has anti-angiogenic properties in vitro and in vivo,” at the Angiogenesis in Cancer and Vascular Disease Congress being held in Miami, Fla. from February 4-8, 2006.
